INTERPACE BIOSCIENCES, INC. Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure of $500.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-06.
Discontinued › Notes
us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure · last filed 2014-03-06
- INTERPACE BIOSCIENCES, INC. concentration risk, credit risk, financial instrument, maximum exposure for fiscal 2013 was $500.00K.
| Period end | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 12 month |
|---|---|
| 2013-12-31 | $500.00K 10-K · filed 2014-03-06 |